>AT1G12460.1 |  leucine-rich repeat transmembrane protein kinase putative 
MRKVHLFLVLVHFIYISTSRSDSISERDILLQFKGSISDDPYNSLASWVSDGDLCNSFNG 
ITCNPQGFVDKIVLWNTSLAGTLAPGLSNLKFIRVLNLFGNRFTGNLPLDYFKLQTLWTI 
NVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPVSLFKFCDKTKFVSLAHNNIFGSI 
PASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYISVRNNLLSGDVSEEIQKCQRLIL 
VDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGEIVDCSESLEFLDASSNELTGRI 
PTGVMGCKSLKLLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSLEFLQV 
LNLHNLNLIGEVPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNRLNGSI 
PPELGNLSKVQFLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQAFGSS 
AFSNNPFLCGDPLVTPCNSRGAAAKSRNSDALSISVIIVIIAAAVILFGVCIVLALNLRA 
RKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDKENIIG 
MGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQGYYFSS 
TMQLILSEFVPNGSLYDNLHLRIFPGTSSSYGNTDLNWHRRFQIALGTAKALSFLHNDCK 
PAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPELAQQSL 
RASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFDRRLREF 
EENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRNGFGS*
>AT5G59680.1 |  leucine-rich repeat protein kinase putative 
MERSLELLLLLIRTLAIIHISQAQSQQGFISLDCGLPANEPSPYTEPRTGLQFSSDAAFI 
QSGKIGRIQANLEADFLKPSTTMRYFPDGKRNCYNLNVEKGRNHLIRARFVYGNYDGRDT 
GPKFDLYLGPNPWATIDLAKQVNGTRPEIMHIPTSNKLQVCLVKTGETTPLISVLEVRPM 
GSGTYLTKSGSLKLYYREYFSKSDSSLRYPDDIYDRQWTSFFDTEWTQINTTSDVGNSND 
YKPPKVALTTAAIPTNASAPLTNEWSSVNPDEQYYVYAHFSEIQELQANETREFNMLLNG 
KLFFGPVVPPKLAISTILSVSPNTCEGGECNLQLIRTNRSTLPPLLNAYEVYKVIQFPQL 
ETNETDVSAVKNIQATYELSRINWQSDPCVPQQFMWDGLNCSITDITTPPRITTLNLSSS 
GLTGTITAAIQNLTTLEKLDLSNNNLTGEVPEFLSNMKSLLVINLSGNDLNGTIPQSLQR 
KGLELLYQGNPRLISPGSTETKSGKSFPVTIVASVGSAAILIVVLVLVLFLRKKKPSAVE 
VVLPRPSRPTMNVPYANSPEPSIEMKKRKFTYSEVTKMTNNFGRVVGEGGFGVVCHGTVN 
GSEQVAVKLLSQSSTQGYKEFKAEVDLLLRVHHTNLVSLVGYCDEGDHLALIYEFVPNGD 
LRQHLSGKGGKPIVNWGTRLRIAAEAALGLEYLHIGCTPPMVHRDVKTTNILLDEHYKAK 
LADFGLSRSFPVGGESHVSTVIAGTPGYLDPDRLSEKSDVYSFGIVLLEMITNQAVIDRN 
RRKSHITQWVGSELNGGDIAKIMDLKLNGDYDSRSAWRALELAMSCADPTSARRPTMSHV 
VIELKECLVSENSRRNMSRGMDTLSSPEVSMIFDAEMIPRAR*
>AT3G46330.1 |  MEE39 (maternal effect embryo arrest 39) kinase 
MKNLCWVFLSLFWFGVFLIIRFAEGQNQEGFISLDCGLPLNEPPYIESETGIQFSSDENF 
IQSGKTGRIPKNLESENLKQYATLRYFPDGIRNCYDLRVEEGRNYLIRATFFYGNFDGLN 
VSPEFDMHIGPNKWTTIDLQIVPDGTVKEIIHIPRSNSLQICLVKTGATIPMISALELRP 
LANDTYIAKSGSLKYYFRMYLSNATVLLRYPKDVYDRSWVPYIQPEWNQISTTSNVSNKN 
HYDPPQVALKMAATPTNLDAALTMVWRLENPDDQIYLYMHFSEIQVLKANDTREFDIILN 
GETINTRGVTPKYLEIMTWLTTNPRQCNGGICRMQLTKTQKSTLPPLLNAFEVYSVLQLP 
QSQTNEIEVVAIKNIRTTYGLSRISWQGDPCVPKQFLWDGLNCNITDISAPPRIISLNLS 
SSGLSGTIVSNFQNLAHLESLDLSNNSLSGIVPEFLATMKSLLVINLSGNKLSGAIPQAL 
RDREREGLKLNVLGNKELCLSSTCIDKPKKKVAVKVVAPVASIAAIVVVILLFVFKKKMS 
SRNKPEPWIKTKKKRFTYSEVMEMTKNLQRPLGEGGFGVVYHGDLNGSEQVAVKLLSQTS 
AQGYKEFKAEVELLLRVHHINLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGGSVL 
NWGTRLQIAIEAALGLEYLHTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGG 
DQSQVSTVVAGTLGYLDPEYYLTSELSEKSDVYSFGILLLEIITNQRVIDQTRENPNIAE 
WVTFVIKKGDTSQIVDPKLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECL 
ASENTRISRNNQNMDSGHSSDQLNVTVTFDTDVKPKAR*
>AT3G03580.1 |  pentatricopeptide (PPR) repeat-containing protein 
MQTRVSSPFISRALSSSSNLNELRRIHALVISLGLDSSDFFSGKLIDKYSHFREPASSLS 
VFRRVSPAKNVYLWNSIIRAFSKNGLFPEALEFYGKLRESKVSPDKYTFPSVIKACAGLF 
DAEMGDLVYEQILDMGFESDLFVGNALVDMYSRMGLLTRARQVFDEMPVRDLVSWNSLIS 
GYSSHGYYEEALEIYHELKNSWIVPDSFTVSSVLPAFGNLLVVKQGQGLHGFALKSGVNS 
VVVVNNGLVAMYLKFRRPTDARRVFDEMDVRDSVSYNTMICGYLKLEMVEESVRMFLENL 
DQFKPDLLTVSSVLRACGHLRDLSLAKYIYNYMLKAGFVLESTVRNILIDVYAKCGDMIT 
ARDVFNSMECKDTVSWNSIISGYIQSGDLMEAMKLFKMMMIMEEQADHITYLMLISVSTR 
LADLKFGKGLHSNGIKSGICIDLSVSNALIDMYAKCGEVGDSLKIFSSMGTGDTVTWNTV 
ISACVRFGDFATGLQVTTQMRKSEVVPDMATFLVTLPMCASLAAKRLGKEIHCCLLRFGY 
ESELQIGNALIEMYSKCGCLENSSRVFERMSRRDVVTWTGMIYAYGMYGEGEKALETFAD 
MEKSGIVPDSVVFIAIIYACSHSGLVDEGLACFEKMKTHYKIDPMIEHYACVVDLLSRSQ 
KISKAEEFIQAMPIKPDASIWASVLRACRTSGDMETAERVSRRIIELNPDDPGYSILASN 
AYAALRKWDKVSLIRKSLKDKHITKNPGYSWIEVGKNVHVFSSGDDSAPQSEAIYKSLEI 
LYSLMAKEGYIPDPREVSQNLEEEEEKRRLICGHSERLAIAFGLLNTEPGTPLQVMKNLR 
VCGDCHEVTKLISKIVGREILVRDANRFHLFKDGTCSCKDRW*